(Virtual Event) International Conference on Molecular Imaging and Clinical PET–CT in the Era of Theranostics (IPET-2020) - Programme - Day 1

Tuesday, 24 November 2020 #IPET2020

OPENING CEREMONY

09:45 - 10:15

General introduction - Diana Paez, IPET-2020 Conference Scientific Secretary, IAEA 

IPET-2020 Official opening - Rafael Mariano Grossi, Director General, IAEA

Welcome remarks - Najat Mokhtar, Deputy Director General, Head of the Department of Nuclear Sciences and Applications, IAEA

Welcome remarks - May Abdel-Wahab, Director, Division of Human Health, Department of Nuclear Sciences and Applications, IAEA

IPET-2020 Administrative remarks - Diana Paez, Section Head, Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, IAEA

PLENARY SESSION 1: Keynote lectures

Chairperson: Wim Oyen, EANM

IAEA Coordinator: Diana Paez

10:15 - 10:30

The Burden of Cancer - Andre Ilbawi, WHO

10:30 - 10:45

Medical Imaging: A Global Perspective - Diana Paez, IAEA

10:45 - 11:10

Artificial Intelligence and Machine Learn­ing - Georg Langs, ESR

11:10 - 11:30 

Impact of Theranostics in Personalized Medicine - Wim Oyen, EANM

11:30 - 11:50

Immunotherapy - Jose Antonio Obando, SNMMI

11:50 - 12:05

Live Q/A

ABSTRACT SESSION 1

12:05 - 12:35  

Chairperson: Henry Bom, ARCCNM

IAEA Coordinator: Miriam Mikhail

Inclusion of PET in radiation treatment planning in lung cancer: Are there clinical impacts? - Rebecca Buecker, Germany (97*)

FDG PET/CT imaging of extra pulmonary tuberculosis immune reconstitution inflammatory syndrome - Osayande Evbuomwan, South Africa (100*)

Visual and quantitative assessment of residual aggressive lymphoma with the Lesion Synthesis Toolbox - Christiane Wiefels, Brazil (216*)

*Abstract number

INTERACTIVE SESSION 1: CT

IAEA Coordinator: Olivier Pellet

12:35 - 12:55

Read with the Expert: CT Abdomen and Pelvis - Alvaro Huete, Pontifical Catholic University of Chile, Chile

12:55 - 13:15

Read with the Expert: CT Thorax - Tom Brian Lynch, Queen’s University Belfast, UK

CLINICAL SESSION 1: Colon Cancer

Chairperson: Giuliano Mariani, University of Pisa, Italy

IAEA Coordinator: Olivier Pellet 

13:15 - 13:35

What the Clinician Needs to Know - Vivek Subbiah, MD Anderson Cancer Center, USA

13:35 - 13:55

Role of PET/CT in Colon Cancer - Homer Macapinlac, MD Anderson Cancer Center, USA

13:55 - 14:10

Live Q/A

CLINICAL SESSION 2: Lung Cancer

Chairperson: Irene Virgolini, WARMTH

IAEA Coordinator: Miriam Mikhail 

14:10 - 14:30

Radiation Therapy in Patients with Lung Cancer - Ciro Franzese, Humanitas Research Hospital - Humanitas University, Italy 

14:30 - 14:50

Role of PET/CT in Solitary Pulmonary Nodule - Elba Etchebehere, University of Campinas, Brazil

14:50 - 15:10

Role of PET/CT in Lung Cancer Staging - Victor Gerbaudo, Brigham and Women’s Hospital, Harvard Medical School, USA

15:10 - 15:30

Role of PET/CT in Radiation Therapy Planning - Arturo Chiti, Humanitas Research Hospital - Humanitas University, Italy 

15:30 - 15:45

Live Q/A

ABSTRACT SESSION 2

15:45 - 16:15

Chairperson: Akram Al-Ibraheem, King Hussein Cancer Center, Jordan

IAEA Coordinator: Francesco Giammarile

Synthesis, characterization and theranostic evaluation of Tc-99m labelled multifunctional superparamagnetic iron oxide nanoparticles: Dual labelled DPAPA (3,5-bis (diphosphono amino) pentanoic acid) conjugated iron oxide prop as a prostate cancer theranostic agent - Volkan Yasakci, Turkey (52*)

Brain perfusion SPECT changes in major depressive disorder patients treated with statins in addition to standard SSRIs therapy, using Neurostat software - Byron Riedel de Juan, Chile (53*)

Dynamic Evaluation Of Volumetric Parameters With [68ga] Ga-Dota-Noc In Patients With Neuroendocrine Tumors Who Received Therapy With [177lu]Lu-Dota-Toc. - Marylin Acuña Hernandez, Colombia (113*)

*Abstract number